Advances in treatment of chronic thromboembolic pulmonary hypertension

Andreas Tzoumas(Aristotle University of Thessaloniki), George Giannakoulas(AHEPA University Hospital), Spyridon Peppas(Athens Naval & Veterans Hospital), Paraschos Archontakis‐Barakakis(Albert Einstein College of Medicine), Μarios Sagris(National and Kapodistrian University of Athens), Adam Taleb(Athens Medical Center), Damianos G. Kokkinidis(Memorial Hospital of South Bend), Christos Bakoyiannis(National and Kapodistrian University of Athens), Christos A. Papanastasiou(Aristotle University of Thessaloniki)
Thrombosis Research
February 12, 2022
10.1016/j.thromres.2022.02.003
Cited by 17

Related Papers

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York
|Metabolism|2020|901
Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity
|JAMA Cardiology|2019|418
Atrial Fibrillation Is Associated with Cognitive Impairment, All-Cause Dementia, Vascular Dementia, and Alzheimer’s Disease: a Systematic Review and Meta-Analysis
|Journal of General Internal Medicine|2021|125
Management of venous thromboembolism in pregnancy
|Thrombosis Research|2022|91